Daveen Chopra sold $205k of EW
CVP, TMTT at Edwards Lifesciences Corp. 2,500 shares at an average of $81.95, traded Aug 25, 2025, filed Aug 25, 2025.
Score components
- +15RoleOfficer
- +12Trade size$205k at market
- 0Share of holdings soldSold 7.5% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-007460, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 25, 2025 | SOpen-market sale Common Stock | -2,500 | $81.95 | $205k | 30,996 | Aug 25, 2025 |
Related signals
Other insiders at Edwards Lifesciences Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $53k 619 shares | -2% | |
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $54k 619 shares | -2% | |
| 4Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $87k 1,019 shares | -3% | |
| 32Weak | Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $1.1M 13,000 shares | -25% | |
| 30Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $974k 11,340 shares | -35% | |
| 75Notable | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $2.0M 24,000 shares | -53% | |
| 48Moderate | Edwards Lifesciences Corp | Bernard J Zovighian CEO | $1.7M 22,430 shares | -21% | |
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $87k 1,019 shares | -4% | |
| 23Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $971k 11,340 shares | -26% | |
| 59Moderate | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $954k 11,386 shares | -23% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.